Pacific Eye Associates
4.8
102 reviews
Dr. Emily Sarah Charlson
4.8
102 reviews
  • 5
  • 4
  • 3
  • 2
  • 1
  • Sort By:
    Google My Business
    Mary Gomes Via Google My Business
    I have been treating at this office for many years and have always been happy with the care I received. However, this was my very first visit with Doctor Charlson.She was very attentive and took time with me during this visit . She explained several things to me, including a condition I was not aware of.I am glad that she is now one of the doctors in the office.
    Google My Business
    Laura Evetts Via Google My Business
    It was great to see someone who specializes in my condition. Emily was very kind and informative. I am going to see her in 6 months for a follow op.
    Google My Business
    shirlese hayes Via Google My Business
    Google My Business
    Courtney Jones Via Google My Business
    On time with the appointment, professional, understood my needs, answered all of my questions to my satisfaction - all in all a great experience.
    Google My Business
    Stephen Eyre Via Google My Business
    Dr. Charlson was friendly and informative.
    << < 9 10 11 12 13 > >>
    Dr. Emily Sarah Charlson
    Dr. Emily Sarah Charlson
    +1(415) 923-3007
    ABOUT
    Dr. Emily Sarah Charlson
    Ophthalmologist Emily Charlson, M.D., Ph.D. is a specialist in oculofacial, orbital, and aesthetic plastic surgery. She is an expert in eyelid, orbit, and tear drainage surgery including droopy eyelids and eyebrows, eyelid bags, eyelid cancer/Mohs reconstruction, eyelid malpositions, thyroid eye disease/decompression, orbital tumors or masses, and tearing due to tear drainage system problems. Dr. Charlson implements the latest medical and surgical therapies including biologics for orbital carcinoma, corneal neurotization (nerve grafting) to restore corneal sensation, and Teprotumumab for thyroid eye disease treatment. Cosmetically, she performs aesthetic eyelid, eyebrow, and midface surgery, as well as injectable fillers/botox and skin resurfacing for full facial rejuvenation. Using the latest minimally invasive techniques, she strives to balance eye function and aesthetics with patient-centered customized approaches. Dr. Charlson graduated from The University of Pennsylvania after a 7-year dual degree MD-PhD medical scientist training program. Her Ph.D. work centered on genomics, deep-sequencing, and bioinformatics with the Human Microbiome Project. She presented her work at numerous national and international conferences with publications in Nature Biotechnology, Nature Methods, and others. Her work is recognized with the University of Pennsylvania Institute for Translational Medicine & Therapeutics Prize for Clinical Translational Research and Jeffery W. Berger Ophthalmology Research Award, among others. She completed her ophthalmology residency at the University of California, Irvine. Here, Dr. Charlson led the development of a novel digital prosthetic eye using OLED micro-screens and 3D printed glasses incorporating a convolutional neural network artificial intelligence algorithm for pupil tracking funded by an Institute for Clinical Translational Research Rising Investigator NIH Grant. This work was presented at several international conferences and recognized with a UCI Research Excellence Award and American Society of Ophthalmic Plastic Surgery (ASOPRS) Innovation & Achievement Award. Dr. Charlson pursued an intensive 2-year American Society of Ophthalmic Plastic Surgery fellowship in oculofacial, orbit, and aesthetics as of one of only a handful of fellows annually selected by ASOPRS with Byers Eye Institute at Stanford University. She received a Heed Fellowship Award from the Society of Heed Fellows and lead significant contributions to survival analysis of globe/eye salvaging therapy for orbital malignancy, use of immune-checkpoint inhibitors for advanced orbital carcinoma, and new methods of corneal neurotization. Most recently, she designed novel artificial intelligence algorithms to predict thyroid eye disease development in newly diagnosed Graves’ and Hashimoto’s disease patients useful for evaluating the risk of thyroidectomy vs radioactive iodine ablation (RAI) in thyroid patients. This work was recognized at international conferences and awarded the ASOPRS Innovation & Achievement Award. Outside of medicine, she loves running/swimming/cycling as a triathlete, taking her two Rhodesian Ridgeback puppies to the beach, and traveling internationally with her family.